VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
-9.21%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$617M
AUM Growth
+$617M
(-16%)
Cap. Flow
+$4.92M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
74.33%
Holding
32
New
6
Increased
3
Reduced
2
Closed
5
Top Buys
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$12.2M |
| 2 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$8.22M |
| 3 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$8.19M |
| 4 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$5.21M |
| 5 |
Altimmune
ALT
|
$4.63M |
Top Sells
| 1 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$13.7M |
| 2 |
Olema Pharmaceuticals
OLMA
|
$7.64M |
| 3 |
CVRx
CVRX
|
$6.52M |
| 4 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$6.42M |
| 5 |
AKYA
Akoya BioSciences
AKYA
|
$6.12M |
Sector Composition
| 1 | Healthcare | 95.22% |
